New ccfDNA data presented at the AMP meeting in Salt Lake City!
back to news
Salt Lake City, Utah/USA
November 16-18, 2017
Have a look at new studies presented at the AMP Annual Meeting - Where Molecular Leads Medicine to Best Practice Care.
In case you missed it at AMP - explore the posters here:
- Analytical Validation of a Circulating Tumor Methylated-DNA Assay for Detection of Colorectal Cancer Recurrence. John Alsobrook1, Snigdha Gaur1, Emily Kinnaman1, Laura Schnetzler1, David Murray2, Sherin Alex2, Robert Boorstein1. 1 Clinical Genomics Pathology Inc., Bridgewater, NJ, USA and 2 Clinical Genomics Technologies Pty Ltd, North Ryde, NSW, Australia.
- Effect of blood collection tubes on circulating tumor DNA (ctDNA) yield and specificity. David Murray1, Nicky Boulter1, Susanne Pedersen1, Lawrence LaPointe1. 1 Clinical Genomics Technologies Pty Ltd, North Ryde, NSW, Australia.
- Performance Evaluation of Collection/Stabilization/Purification Systems for Liquid Biopsy Cancer Biomarker Applications. 1 Daniel Groelz, 1 Tomasz Krenz, 1 Ricardo Huebel, 2 Natasha Cant, 2 Maryam Zahedi-Nejad, 3 Hans Attig, 1 Nadine Dettmann and 1 Thorsten Voss. 1 PreAnalytiX GmbH, Hilden, Germany; 2 QIAGEN Ltd., Manchester, United Kingdom; 3 QIAGEN GmbH, Hilden, Germany.